Arvinas Announces Changes to its Board of Directors

NEW HAVEN, Conn., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

Related Keywords

United States ,Canada ,American ,John Houston ,Jeff Boyle ,Asia Pacific ,Brad Margus ,Kirsten Owens ,Everett Cunningham ,Exchange Commission ,Pfizer ,Arvinas Inc ,Quest Diagnostics ,Northwestern University ,Nasdaq ,Audit Committee ,Chief Executive Officer ,Arvina Board ,Chief Commercial Officer ,Exact Sciences ,Senior Vice President ,Regional President ,Established Products ,American Family Children ,Visby Medical ,San Jose ,Discovery Engine ,Nasdaq Arvn ,Rvinas Inc ,Breast Cancer ,Prostate Cancer ,Argetedproteindegradation ,Immuno Oncology ,Ncology ,Protac ,Protein Degradation ,